EANS-Adhoc: LifeWatch AG
Nominates National Councillor Jürg Stahl, member of
the Swiss Parliament, as Candidate for the Board of Directors
ad-hoc disclosure transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is solely responsible for the content of this announcement.
Company Information
15.04.2010
Neuhausen am Rheinfall / Switzerland, April 15, 2010 - LifeWatch AG (SIX Swiss Exchange: LIFE), the leading wireless remote cardiac and medical patient monitoring service provider in the U.S., announces the nomination of National Councillor Jürg Stahl (Canton of Zurich / SVP) for election to the Board of Directors of LifeWatch AG. Ruedi Stoeckly, who has been Member of the Board of Directors for many years, will not be available for re-election at the upcoming Annual Shareholder Meeting.
The Board of Directors of LifeWatch AG proposes to the next Annual Shareholder Meeting on May 26th, 2010, to elect National Councillor Jürg Stahl (SVP) as a new member of the Board of Directors for a term of office of one year. As National Councillor of the Canton of Zurich, Mr. Jürg Stahl is a member of the House of Representatives of Switzerland, where he is highly regarded as an experienced healthcare expert. His work in various Federal Commissions includes his membership of the Federal Commission for Social Security and Healthcare of the Swiss National Council (SGK-NR) since 1999. His professional background as a member of Executive Board of the health insurance company Group Mutuel will be an additional asset for the Board of Directors of LifeWatch AG.
After the success of its monitoring services in the U.S., LifeWatch now intends to expand its services into attractive healthcare markets in Europe. Consequently the company is seeking to complement its Board with an experienced politician in the field of healthcare who can serve the company with his valuable network in Switzerland and beyond, including contacts at companies, authorities, and service providers in the healthcare industry.
National Councillor Jürg Stahl will succeed Ruedi Stoeckly who has served as a Member of the Board since 2003 and who will not be available for re-election. The Board of Directors would like to thank Mr. Stoeckly for his valuable contributions during the past years and wishes him all the best. Apart from Chairman Yacov Geva, who has a mandate until 2011, all other Members including Vice Chairman Urs Wettstein, Gregory Henry Volkart and Dr. Abraham Sartani are due for re-election at the Annual General Meeting for a term of office of one year.
About LifeWatch AG LifeWatch AG, headquartered in Neuhausen am Rheinfall and listed on SIX Swiss Exchange (LIFE), Switzerland, is the leading healthcare technology and solution company, specializing in advanced telehealth systems and wireless remote patient monitoring services. LifeWatch services cater to individuals, ranging from high-risk and chronically ill patients, to consumers of health and wellness products. LifeWatch has subsidiaries in the United States, the Netherlands, Japan, the United Kingdom, Switzerland and Israel. LifeWatch AG is the parent company of LifeWatch Services Inc., a leading US-based cardiac monitoring service provider, and manufacturer of telecardiology products.
LifeWatch is also introducing a new program for Home SleepTesting of Obstructive Sleep Apnea (OSA) patients under the brand name NiteWatch. For additional information, please visit www.lifewatch.com and www.nitewatchservices.com
Sign-up for customized e-mail alerts and documentation requests is available at http://production.investis.com/lifewatch/alert-service/
This press release includes forward-looking statements. All statements other than statements of historical facts contained in this press release, including statements regarding future results of operations and financial position, business strategy and plans and objectives for future operations, are forward- looking statements. The words "believe," "may," "will," "estimate," "continue," "anticipate," "intend," "expect" and similar expressions are intended to identify forward-looking statements. LifeWatch AG has based these forward looking statements largely on current expectations and projections about future events and financial trends that it believes may affect the financial condition, results of operations, business strategy, short term and long term business operations and objectives, and financial needs. These forward-looking statements are subject to a number of risks, uncertainties and assumptions. In light of these risks, uncertainties and assumptions, the forward-looking events and circumstances described may not occur and actual results could differ materially and adversely from those anticipated or implied in the forward- looking statements. All forward-looking statements are based only on data available to LifeWatch AG at the time of the issue of this press release. LifeWatch AG does not undertake any obligation to update any forward-looking statements contained in this press release as a result of new information, future events or otherwise.
THIS PRESS RELEASE IS NOT BEING ISSUED IN THE UNITED STATES OF AMERICA AND SHOULD NOT BE DISTRIBUTED TO UNITED STATES PERSONS OR PUBLICATIONS WITH A GENERAL CIRCULATION IN THE UNITED STATES. THIS PRESS RELEASE DOES NOT CONSTITUTE AN OFFER OF SECURITIES OF LIFEWATCH AG OR ANY OF ITS SUBSIDIARIES FOR SALE IN THE UNITED STATES OR AN INVITATION TO SUBSCRIBE FOR OR PURCHASE ANY SECURITIES OF LIFEWATCH AG OR ITS SUBSIDIARIES IN THE UNITED STATES. IN ADDITION, THE SECURITIES OF LIFEWATCH AG AND ITS SUBSIDIARIES HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES LAWS AND MAY NOT BE OFFERED, SOLD OR DELIVERED WITHIN THE UNITED STATES OR TO U.S. PERSONS ABSENT REGISTRATION UNDER OR AN APPLICABLE EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE UNITED STATES SECURITIES LAWS. ANY PUBLIC OFFERING OF SECURITIES TO BE MADE IN THE UNITED STATES WILL BE MADE BY MEANS OF A PROSPECTUS THAT MAY BE OBTAINED FROM LIFEWATCH AG OR ITS SUBSIDIARIES, AS APPLICABLE, AND WILL CONTAIN DETAILED INFORMATION ABOUT THE ISSUER AND ITS MANAGEMENT AS WELL AS FINANCIAL STATEMENTS OF THE ISSUER.
end of announcement euro adhoc
Further inquiry note:
For further information on LifeWatch please contact:
Kobi Ben Efraim, Chief Financial Officer, LifeWatch AG
Tel +41 52 632 00 50 | Fax +41 52 632 00 51 | E-mail kobibe@lifewatch.com
Sensus Investor & Public Relations GmbH, Zürich:
Tel +41 43 366 55 11 | Fax +41 43 366 55 12 | E-mail lifewatch@sensus.ch
Branche: Healthcare Providers
ISIN: CH0012815459
WKN: 1281545
Index: SPI, SPIEX
Börsen: Frankfurt / Open Market / XETRA
SIX Swiss Exchange / Hauptsegment
Berlin / free trade